Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Verici Dx (VRCI) Share Price

Price 0.475p on 01-05-2026 at 18:50:10
Change 0.005p 1.05%
Buy 0.50p
Sell 0.45p
Last Trade: Buy 20,000.00 at 0.48p
Day's Volume: 2,397,849
Last Close: 0.48p
Open: 0.475p
ISIN: GB00BM8HZD43
Day's Range 0.475p - 0.48p
52wk Range: 0.449p - 1.625p
Market Capitalisation: £7.26m
VWAP: 0.437213p
Shares in Issue: 1.51b

Verici Dx (VRCI) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 20,000 0.48p Suspected BUY Trade
16:35:26 - 01-May-26
Sell* 213,551 0.465p Ordinary
14:32:30 - 01-May-26
Sell* 19,882 0.468p Ordinary
14:19:20 - 01-May-26
Sell* 1,000,000 0.43p Negotiated Trade
13:45:56 - 01-May-26
Buy* 115,000 0.48p Suspected BUY Trade
11:00:16 - 01-May-26
Buy* 1,592 0.50p Ordinary
08:41:17 - 01-May-26
Buy* 1,592 0.50p SI Trade
08:41:17 - 01-May-26
Buy* 1,592 0.50p Ordinary
08:39:02 - 01-May-26
Sell* 28 0.45p SI Trade
08:39:02 - 01-May-26
Buy* 28 0.50p SI Trade
08:39:02 - 01-May-26
See more Verici Dx trades

Verici Dx (VRCI) Share Price History

Time period:
to
Date Open High Low Close Volume
1st May 2026 (Fri) 0.475 0.48 0.475 0.48 2,397,849
30th Apr 2026 (Thu) 0.475 0.50 0.475 0.475 714,700
29th Apr 2026 (Wed) 0.475 0.475 0.475 0.475 60,627
28th Apr 2026 (Tue) 0.525 0.55 0.475 0.475 1,131,150
27th Apr 2026 (Mon) 0.525 0.525 0.525 0.525 20,996
24th Apr 2026 (Fri) 0.525 0.525 0.525 0.525 1,709,887
23rd Apr 2026 (Thu) 0.525 0.525 0.525 0.525 348,999
22nd Apr 2026 (Wed) 0.525 0.525 0.525 0.525 29,703
21st Apr 2026 (Tue) 0.525 0.525 0.525 0.525 71,880
20th Apr 2026 (Mon) 0.525 0.525 0.525 0.525 922,938
17th Apr 2026 (Fri) 0.525 0.525 0.525 0.525 4,770,303
16th Apr 2026 (Thu) 0.60 0.52 0.50 0.52 8,751,286
15th Apr 2026 (Wed) 0.475 0.475 0.475 0.475 23,751
14th Apr 2026 (Tue) 0.475 0.475 0.475 0.475 240
13th Apr 2026 (Mon) 0.475 0.475 0.475 0.475 139,025
10th Apr 2026 (Fri) 0.475 0.475 0.475 0.475 2,420,914
9th Apr 2026 (Thu) 0.475 0.475 0.475 0.475 1,321,983
8th Apr 2026 (Wed) 0.475 0.475 0.475 0.475 1,090,557
7th Apr 2026 (Tue) 0.475 0.475 0.449 0.475 753,808
6th Apr 2026 (Mon) 0.475 0.475 0.475 0.475 0
3rd Apr 2026 (Fri) 0.475 0.475 0.475 0.475 0
See more Verici Dx price history

Verici Dx (VRCI) Regulatory News

Date Source Headline
30th Apr 2026 4:30 pm RNS Holding(s) in Company
24th Apr 2026 5:19 pm RNS Holding(s) in Company
16th Apr 2026 7:00 am RNS Positive Q1 Trading Update
10th Apr 2026 3:24 pm RNS Holding(s) in Company
7th Apr 2026 5:20 pm RNS Holding(s) in Company
31st Mar 2026 7:00 am RNS Board Change
5th Feb 2026 7:01 am RNS FY25 Trading Update
5th Feb 2026 7:00 am RNS Agreement with BCBS of Illinois for Tutivia™
12th Nov 2025 7:00 am RNS-R Completion of CAP accreditation audit
6th Nov 2025 7:00 am RNS Provider Participation Agreement with Prime Health
See more Verici Dx regulatory news

Verici Dx (VRCI) Share News

WINNERS & LOSERS: Riverstone redeems shares; IQE raises GBP513 million

28th Apr 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

EARNINGS AND TRADING: Norcros sales up; eEnergy eyes record first-half

16th Apr 2026 14:38

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Animalcare agrees to bid; Alumasc lowers forecast

16th Apr 2026 12:02

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

EARNINGS AND TRADING: React sales increase; Arcontech profit declines

5th Feb 2026 20:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Verici passes laboratory inspection by US accreditor

12th Nov 2025 18:05

Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Completes second biennial inspection of its clinical laboratory, accredited by the College of American Pathologists. Verici says the inspection, passed with no deficiencies, shows its "commitment to compliance and maintaining excellence in daily clinical laboratory operations according to CAP requirements". Adds: "By continuing to follow these strict CAP guidelines and pass CAP accreditation audits, Verici Dx can consistently provide reliable test results under its quality management system and further improve patient health." Read More

See more Verici Dx news
FTSE 100 Latest
Value10,363.93
Change-14.89

Login to your account

Forgot Password?

Not Registered